Bretylium tosylate intravenous admixture compatibility. I: Stability in common large-volume parenteral solutions.
The stability of bretylium tosylate in 11 common large-volume parenteral solutions was studied. Two containers of each solution, one glass and one plastic (except for mannitol and sodium bicarbonate solutions, which were available in glass only), were stored at each of the following conditions: intense light (1400-2000 foot candles), ambient room temperature with normal light, 40 degrees C, and 4 degrees C. All samples were tested at 0 and 24 hours; some samples were also tested at 48 hours and 7 days. Testing included measurement for optical density at 4000 and 600 nm, pH level, and bretylium content as determined by HPLC. The admixtures remained clear and colorless, except that mannitol precipitated out of mannitol solutions stored at 4 degrees C. No appreciable changes in pH were observed. HPLC assays showed no significant changes in bretylium tosylate concentrations. Bretylium tosylate is compatible with each of the 11 common intravenous solutions chosen for investigation under the storage conditions studied. Admixtures with mannitol should not be refrigerated, because mannitol crystallizes from solution at refrigerator temperatures.
D001949:Bretylium Compounds / Q000032:analysis; D001950:Bretylium Tosylate / Q000032:analysis; D004338:Drug Combinations; D004344:Drug Incompatibility; D004355:Drug Stability; D007263:Infusions, Parenteral; D012996:Solutions
D001949:Bretylium Compounds; D004338:Drug Combinations; D012996:Solutions; D001950:Bretylium Tosylate